These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3600916

  • 1. Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child.
    Peces R, Riera JR, López Larrea C, Alvarez J.
    Nephron; 1987; 46(1):78-82. PubMed ID: 3600916
    [Abstract] [Full Text] [Related]

  • 2. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
    García Donaire JA, Manzanera MI, Valentín MO, Espejo B, Gutiérrez Martínez E, Praga M.
    Nefrologia; 2004; 24(2):179-82. PubMed ID: 15219093
    [Abstract] [Full Text] [Related]

  • 3. Conventional therapy for idiopathic nephrotic syndrome in children.
    Brodehl J.
    Clin Nephrol; 1991; 35 Suppl 1():S8-15. PubMed ID: 1860269
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
    Tejani A, Phadke K, Nicastri A, Adamson O, Chen CK, Trachtman H, Tejani C.
    Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
    [Abstract] [Full Text] [Related]

  • 5. HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome.
    Konrad M, Mytilineos J, Ruder H, Opelz G, Schärer K.
    Pediatr Nephrol; 1997 Feb; 11(1):16-9. PubMed ID: 9035165
    [Abstract] [Full Text] [Related]

  • 6. Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetes.
    Goldman M, Hébert D, Geary DF.
    Pediatr Nephrol; 2002 May; 17(5):351-4. PubMed ID: 12042892
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
    Jones DP, Stapleton FB, Roy S, Wyatt RJ.
    Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028
    [Abstract] [Full Text] [Related]

  • 8. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome.
    Kemper MJ, Altrogge H, Ludwig K, Timmermann K, Müller-Wiefel DE.
    Pediatr Nephrol; 2000 Aug; 14(8-9):772-5. PubMed ID: 10955925
    [Abstract] [Full Text] [Related]

  • 9. Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis.
    Ponticelli C, Rivolta E.
    Am J Nephrol; 1990 Aug; 10 Suppl 1():105-9. PubMed ID: 2256469
    [Abstract] [Full Text] [Related]

  • 10. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R, de Jong M, Monnens L.
    Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
    [Abstract] [Full Text] [Related]

  • 11. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
    García Camín RM, Cabezas A, Calero F, Ballarín JA.
    Nefrologia; 2004 May 02; 24 Suppl 3():68-71. PubMed ID: 15219073
    [Abstract] [Full Text] [Related]

  • 12. [Primary corticosteroid-resistant nephrotic syndrome in pediatrics].
    Tuya CO, Muñoz M, Costa JA, Repetto HA.
    Medicina (B Aires); 1984 May 02; 44(1):1-7. PubMed ID: 6535901
    [No Abstract] [Full Text] [Related]

  • 13. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ, Wetzels JF.
    Ned Tijdschr Geneeskd; 1998 Dec 26; 142(52):2832-8. PubMed ID: 10065257
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
    Kashtan C, Melvin T, Kim Y.
    Clin Nephrol; 1988 Feb 26; 29(2):79-85. PubMed ID: 3359697
    [Abstract] [Full Text] [Related]

  • 15. Childhood nephrotic syndrome: clinical associations and response to therapy.
    Grupe WE.
    Postgrad Med; 1979 May 26; 65(5):229-31, 234-6. PubMed ID: 432155
    [Abstract] [Full Text] [Related]

  • 16. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R, Brem AS.
    Pediatrics; 1989 Sep 26; 84(3):495-9. PubMed ID: 2771553
    [Abstract] [Full Text] [Related]

  • 17. Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome.
    Trachtman H, Carroll F, Phadke K, Khawar M, Nicastri A, Chen CK, Tejani A.
    Am J Nephrol; 1987 Sep 26; 7(1):13-7. PubMed ID: 3578368
    [Abstract] [Full Text] [Related]

  • 18. Steroid responsive nephrotic syndrome in a diabetic patient.
    Reddy J, Simpson IJ, Doak PB.
    N Z Med J; 1985 Feb 13; 98(772):76-7. PubMed ID: 3856153
    [No Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide in treatment of minimal change nephrotic syndrome.
    Shohet I, Meyerovitch J, Aladjem M, Boichis H.
    Eur J Pediatr; 1988 Apr 13; 147(3):239-41. PubMed ID: 3391218
    [Abstract] [Full Text] [Related]

  • 20. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
    Gilbert RD, Hulse E, Rigden S.
    Pediatr Nephrol; 2006 Nov 13; 21(11):1698-700. PubMed ID: 16932900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.